VOLUME 12 - ISSUE 1 | May 2021COVER STORY
Cancer in Focus
The latest insights and updates on cancer screening and diagnostics
Insight
|
Do Cancer Genetic Testing Criteria Need an Overhaul?
Universal genetic testing could offer a middle ground between guideline-based and population-based testing
|
How the Pandemic Has Impacted Cancer Screening
Delayed cancer screening due to COVID-19 could mean more cancer-related deaths for years to comeManagement
|
Strategies to Improve Lab Staff Retention
How to build stronger working relationships that will ultimately reduce staff turnover
Technology
|
Flow Cytometry for Immuno-Oncology: Best Practices
Consider these key factors for a successful, reproducible flow cytometry assayThought Leadership
|
An Inside View of Brain Tumors
A new blood test may soon allow clinicians to diagnose brain tumors without surgical biopsy
|
Novel Complex Cell Manufacturing
Challenges and critical considerations for the manufacturing of cellular therapies
|
The Technologies that Helped COVID-19 Testing Labs Scale Up
Lab automation can help labs overcome challenges exacerbated by the pandemic to increase testing
|
The Evolution of Clinical Flow Cytometry
A look at the technological advances that have simplified the use of flow cytometry in clinical labsBusiness
|
Changes to FDA Oversight of Lab-Developed Tests
The decision to revoke FDA oversight of LDTs is no longer clear after HHS removed its initial statement
|
